New shot shows promise for Tough-to-Treat blood cancer
NCT ID NCT06223516
First seen Jan 08, 2026 · Last updated May 02, 2026 · Updated 16 times
Summary
This study tests an experimental drug called etentamig in about 55 adults with multiple myeloma that has returned or not improved after prior treatments. The drug is given as a shot under the skin or through an IV. The main goals are to check safety, how the drug moves through the body, and whether it helps control the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atrium Health Wake Forest Baptist Medical Center /ID# 260807
Winston-Salem, North Carolina, 27157, United States
-
Hadassah Medical Center-Hebrew University /ID# 261446
Jerusalem, Jerusalem, 91120, Israel
-
Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital /ID# 265286
Nagoya, Aichi-ken, 466-8650, Japan
-
Kindai University Hospital /ID# 266016
Sakai-shi, Osaka, 590-0197, Japan
-
Mayo Clinic - Rochester /ID# 262807
Rochester, Minnesota, 55905-0001, United States
-
Mayo Clinic Arizona /ID# 260799
Phoenix, Arizona, 85054, United States
-
Mayo Clinic Hospital Jacksonville /ID# 262808
Jacksonville, Florida, 32224, United States
-
Sylvester Comprehensive Cancer Center /ID# 260798
Miami, Florida, 33136-1002, United States
-
Tel Aviv Sourasky Medical Center /ID# 261525
Tel Aviv, Tel Aviv, 6423906, Israel
-
The Chaim Sheba Medical Center /ID# 261699
Ramat Gan, Tel Aviv, 5265601, Israel
-
Universitaetsklinikum Frankfurt /ID# 260442
Frankfurt am Main, Hesse, 60590, Germany
-
Universitaetsklinikum Hamburg-Eppendorf /ID# 260444
Hamburg, 20246, Germany
-
Universitaetsklinikum Koeln /ID# 260445
Cologne, North Rhine-Westphalia, 50937, Germany
-
University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 261050
Ann Arbor, Michigan, 48109, United States
-
Wisconsin Medical Center /ID# 261085
Milwaukee, Wisconsin, 53226, United States
Conditions
Explore the condition pages connected to this study.